Xinqiang Song
- Molecular Medicine top 5%
-
- Natural Compounds in Disease Treatment 6
- Biochemistry top 10%
- Pharmacology top 5%
-
- Rheumatoid Arthritis Research and Therapies 7
-
- Ferroptosis and cancer prognosis 5
-
- Immunotherapy and Immune Responses 4
- T-cell and B-cell Immunology 4
-
- Monoclonal and Polyclonal Antibodies Research 4
-
- Tea Polyphenols and Effects 4
-
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Tiantian ZhaoShuai WangChao LiYu ZhangBo LuoLei WangHongtao DuMu Zhang
In The Last Decade
Xinqiang Song
37 papers receiving 920 citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Molecular Medicine 80
- Complementary and alternative medicine 113
- Biochemistry 61
- Pharmacology 88
- Biological Psychiatry 23
Countries citing papers authored by Xinqiang Song
This map shows the geographic impact of Xinqiang Song's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xinqiang Song with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xinqiang Song more than expected).
Fields of papers citing papers by Xinqiang Song
This network shows the impact of papers produced by Xinqiang Song. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xinqiang Song. The network helps show where Xinqiang Song may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xinqiang Song, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 6 | |
| 6 | 2022 | 9 | |
| 7 | 2021 | 67 | |
| 8 | 2021 | 15 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 70 | |
| 11 | 2019 | 48 | |
| 12 | 2017 | 25 | |
| 13 | 2016 | 2 | |
| 14 | 2016 | 7 | |
| 15 | 2016 | 6 | |
| 16 | 2013 | 25 | |
| 17 | 2013 | 10 | |
| 18 | 2010 | 53 | |
| 19 | 2008 | 32 | |
| 20 | 2008 | 24 |
About Xinqiang Song
Xinqiang Song is a scholar working on Applied Microbiology and Biotechnology, Complementary and alternative medicine and Molecular Medicine, having authored 41 papers that have together received 945 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (7 papers), Natural Compounds in Disease Treatment (6 papers), Ferroptosis and cancer prognosis (5 papers), Immunotherapy and Immune Responses (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Tea Polyphenols and Effects (4 papers), T-cell and B-cell Immunology (4 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Molecular Medicine (80 citations), Complementary and alternative medicine (113 citations) and Biochemistry (61 citations). Xinqiang Song has collaborated with scholars based in China, Hong Kong and Singapore. Frequent co-authors include Tiantian Zhao, Shuai Wang, Chao Li, Yu Zhang, Bo Luo, Lei Wang, Hongtao Du, Mu Zhang, Yuan Luo and Qingsong Lin. Their work appears in journals such as PLoS ONE, Scientific Reports and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.